# Pomalidomide

NDC: 69097-037
Generic name: Pomalidomide
Labeler / Manufacturer: Cipla USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20260830

FDA application: ANDA219718

## Active ingredients

- POMALIDOMIDE: 2 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69097-037"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69097-037
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a0c16478-1a0c-4be0-be75-cb9e4543d71a